BioLase Inc. Stock
Pros and Cons of BioLase Inc. in the next few years
Pros
?
C******** o* t** e**********
?
M***** P*******
?
G***** c******* t* c**********
Cons
?
B****
?
W********* I********* f** t** n*** y****
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of BioLase Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| BioLase Inc. | - | - | - | - | - | - | - |
| InVivo Therapeutics Holdings | - | 3.145% | 77.489% | -71.278% | -52.326% | -99.931% | -99.964% |
| Star Equity Holdings Inc. | 3.640% | 5.556% | 5.556% | 31.538% | -9.043% | -63.771% | -86.703% |
| Atossa Genetics Inc | -0.280% | 0.142% | -13.814% | 141.852% | 49.841% | -27.094% | -62.340% |
Comments
BIOLASE, Inc. (NASDAQ: BIOL) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for BIOL provided by MarketBeat
BIOLASE, Inc. (NASDAQ: BIOL) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for BIOL provided by MarketBeat
BIOLASE, Inc. (NASDAQ: BIOL) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for BIOL provided by MarketBeat